OptimizeRx Corp. (NASDAQ: OPRX), a leading healthcare technology company providing digital health solutions for life sciences companies, announced that it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility consists of a $25 million term loan and a $10 million revolving credit facility, which was undrawn at closing. Roth Capital Partners served as financial advisor on the transaction.
This new credit facility is expected to provide OptimizeRx with additional financial flexibility to support its strategic growth initiatives. The company plans to use the proceeds for general corporate purposes, including potential acquisitions, working capital, and other investments. The facility's structure, with a term loan and a revolving line of credit, offers the company a balanced approach to funding its operations while maintaining liquidity.
OptimizeRx is known for its innovative platform that combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between healthcare provider (HCP) and direct-to-consumer (DTC) strategies, the company empowers brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.
The announcement highlights OptimizeRx's commitment to patient-centric technology and its role in transforming the healthcare landscape. The company partners with some of the world's leading pharmaceutical and life sciences companies to deliver life-changing therapies to the right patients at the right time.
For more information about OptimizeRx and its solutions, visit www.optimizerx.com.
